CN1297552C - Process for synthesizing luteolin - Google Patents

Process for synthesizing luteolin Download PDF

Info

Publication number
CN1297552C
CN1297552C CNB2004100047907A CN200410004790A CN1297552C CN 1297552 C CN1297552 C CN 1297552C CN B2004100047907 A CNB2004100047907 A CN B2004100047907A CN 200410004790 A CN200410004790 A CN 200410004790A CN 1297552 C CN1297552 C CN 1297552C
Authority
CN
China
Prior art keywords
luteolin
dimethoxy
dihydroxyflavone
reaction
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2004100047907A
Other languages
Chinese (zh)
Other versions
CN1666987A (en
Inventor
陈新
梅以成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAIER BIOLOGICAL CHEMICAL CO Ltd NANJING
Original Assignee
LAIER BIOLOGICAL CHEMICAL CO Ltd NANJING
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAIER BIOLOGICAL CHEMICAL CO Ltd NANJING filed Critical LAIER BIOLOGICAL CHEMICAL CO Ltd NANJING
Priority to CNB2004100047907A priority Critical patent/CN1297552C/en
Publication of CN1666987A publication Critical patent/CN1666987A/en
Application granted granted Critical
Publication of CN1297552C publication Critical patent/CN1297552C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The present invention relates to a novel luteolin synthesis method which uses phloroglucinol dihydrate as initial raw material. No protecting group is required. The initial raw material is directly condensed with 3, 4 dimethoxy ethyl benzoylacetate, and thus, 3', 4' dimethoxy and 5, 7 dihydroxyflavone are obtained. Moreover, demethylate is catalyzed by aluminium trichloride or pyridine so as to obtain luteolin. A total yield rate is 34.2%.

Description

The synthetic method of luteolin
Invention field
The present invention relates to organic medicinal chemistry and functional food chemical field, particularly, the present invention relates to the new complete synthesis manufacturing process of cough-relieving, expelling phlegm drugs and functional food luteolin.
Background technology
The chemistry of luteolin is by name: 3 ', 4 ', 5, and the 7-kaempferol; English name: Luteolin.Molecular formula: C 15H 10O 6Molecular weight: 286.24; CAS:[491-70-3].
Luteolin has another name called cinaroside unit, is the common effective ingredient of separating in the Herba Ajugae of effective herbal medicine gold Herba Dracocephali Integrifolii of Xinjiang treatment trachitis and Anhui product.Its natural product have been applied to the clinical treatment cough-relieving, have eliminated the phlegm, anti-inflammatory has curative effect preferably.But because natural product extraction yield is lower, purifying is difficult, and clinical application has certain difficulty.Also many about the report of semi-synthetic luteolin both at home and abroad.Semi-synthetic major part is to be starting raw material with the hesperidine, obtain luteolin (Xing Youquan etc. through dehydrogenation, hydrolysis, demethyl three-step reaction, Chinese Journal of Pharmaceuticals, 25 (11) 484-487), or with the hesperidine is that starting raw material is through hydrolysis, demethyl and dehydrogenation, obtain product (Sun Zhizhong etc. equally, contemporary Chinese is used pharmaceutical journal, 16 (1) 30-31,1999), the technological process more complicated, cost is higher.
The report of relevant complete synthesis luteolin mainly is cinnamophenone (Chalkone) route, and report (W.A.Hutchins, J.Chem.Soc, 91-94,1939) is abroad early arranged.Domestic have a report: with the Phloroglucinol be starting raw material routinely the Hoesch rule get 2,4, the 6-trihydroxy-acetophenone, go up dihydroxyl and the synthetic corresponding cinnamophenone of isovanillin condensation, 6 days consuming time with 4,6 of methyl protections, yield is on the low side, again through the cyclization oxidation, and the hydroiodic acid HI demethylation, the luteolin total recovery is 3-5% only, and there is byproduct aurones (also claiming to do), influences quality product (Lu Yuhua etc., Acta Pharmaceutica Sinica, 15 (8), 1980); Then have report to protect the phenolic hydroxyl group elder generation synthesizing chalcone of corresponding aldehyde, ketone by chloromethyl methyl ether, and then prepare the poly-hydroxy flavones, yield is increased to 22% (Ge Xia etc., Chinese Journal of Pharmaceuticals, 34 (4) 2003).But using the carcinogenic compound chloromethyl ether is inappropriate as protective material.
In addition; complete synthesis luteolin still has 1; 3 replace method (D.Nagarathnam et al, J.Org.Chem, 56 (16) of propane diketone; 4884-4887; 1991), intermediate is wanted the protected silane hydroxyl, uses LIHMDS polyanion lithium; reaction conditions is inflated with nitrogen and-78 ℃, is difficult to realize scale production.
In the complete synthesis process of luteolin, we have studied a large amount of documents and experimentation, unit process, with reference to 3 ', 4 '-benzyloxy-5 of Robert Te Wule, the synthetic method of 7-dihydroxyflavone, (Robert Teoule, etal, Bull.Soc.Chim.France, 546,1961) invented the new complete synthesis manufacture method of luteolin, and optimized technology by pilot scale.
Goal of the invention
The purpose of this invention is to provide a kind of direct be raw material and 3 with Phloroglucinol, 4-dimethoxy benzoyl acetic acid ethyl ester, down dealcoholysis dehydration of temperature in a vacuum, cyclization after the promptly first condensation obtains 3 ', 4 '-dimethoxy-5, the 7-dihydroxyflavone; Then at catalyst A lCl 3/ pyridine exists down, and two methyl sloughing on 3 ', 4 ' promptly obtain luteolin.
Summary of the invention
One of content of the present invention has provided a kind of with intermediate 3 ', 4 '-dimethoxy-5, and the method for 7-dihydroxyflavone demethylation is made luteolin:
The present invention is with 3 ', 4 '-dimethoxy-5, and the 7-dihydroxyflavone is a raw material, with aluminum chloride/pyridine is catalyzer, is solvent with the pyridine, carries out 3-5 hour reaction in temperature under as 160 ℃ of-180 ℃ of normal pressures, be hydrolyzed, wash, remove aluminium salt mother liquor then, obtain crude product, use DMF/H 2O and 95% ethyl alcohol recrystallization.
Two of content of the present invention has provided a kind of directly with Phloroglucinol and 3, and moderate temperature (as 140 ℃-160 ℃) is carried out condensation to 4-dimethoxy malonaldehydic acid ethyl ester under vacuum, cyclization prepares intermediate 3 ', 4 '-dimethoxy-5, the 7-dihydroxyflavone:
Figure C20041000479000042
The present invention need not to protect two hydroxyls of Phloroglucinol; directly with 3 of easy preparation; 4-dimethoxy benzoyl acetic acid ethyl ester is in the presence of high boiling solvent such as phenyl ether or oil of mirbane; moderate temperature under vacuum (as 140 ℃-160 ℃) dealcoholysis dehydration down; obtained intermediate 3 ' in coreaction 6-7 hour; 4 '-dimethoxy-5,7-dihydroxyflavone, wherein vacuum tightness 1330Pa-6600Pa preferably.
3,4-dimethoxy benzoyl acetic acid ethyl ester is by (Wu Anxin etc., " chemical reagent ", 1998,20 (6), 376-377) preparation.
Advantage of the present invention is: technological process is brief, reaction conditions is gentle, and is easy to operate, makes suitability for industrialized production feasible, do not have the aurones by product substantially, and product quality is guaranteed, luteolin total recovery 34.2%, and the yield height is better than the method for other operational paths.
The invention will be further described below by embodiment.It should be understood that the described preparation method of the embodiment of the invention is only used for illustrating the present invention, rather than limitation of the present invention, the simple modifications to preparation method of the present invention under design prerequisite of the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percentage ratio among the present invention is weight percentage.
Embodiment
The preparation of embodiment one, luteolin
With 30Kg 3 ', 4 '-dimethoxy-5, the pure anhydrous pyridine of 7-dihydroxyflavone and 120Kg adds in the enamel reaction still, stir, make dissolving, heating slowly is increased to temperature about 100 ℃, add aluminum chloride in batches, a large amount of heat releases, controlled temperature is no more than 180 ℃, adds aluminum chloride in about 1 hour.Adding the back and reacted 3-5 hour between 160 ℃-180 ℃, whether complete, and definite reaction times if following the tracks of demethyl by high performance liquid phase.
With 1000Kg water suction hydrolysis kettle, be cooled to 10 ℃ in advance, while hot above-mentioned reactant is put into hydrolysis kettle and stirs, get rid of gas, cooling, separate in the whizzer crude product.Use the 50Kg cold water washing, use DMF/H 2O and 95% ethanol secondary recrystallization get luteolin 22.1Kg, yield 81%, and content HPLC 〉=98.5%, product and the contrast of natural luteolin, mass spectrum, infrared spectra are all consistent.
Embodiment two, 3 ', 4 '-dimethoxy-5, the preparation of 7-dihydroxyflavone
With 20Kg Phloroglucinol and 60Kg 3,4-dimethoxy benzoyl acetic acid ethyl ester adds in the enamel reaction still, stir, dissolve, heat, be warming up to 140 ℃-160 ℃, under vacuum (1330Pa) decompression, refluxed 2 hours, cold slightly input 80Kg phenyl ether, again under vacuum (6600Pa) decompression 140 ℃-160 ℃ back flow reaction 4-5 hour, cooling, when being chilled to 30 ℃, suction filtration is used 40Kg95% alcohol immersion 30 minutes, making beating, whizzer gets rid of filter, get 3 ', 4 '-dimethoxy-5, the yellow crude product 21Kg of 7-dihydroxyflavone.The mother liquor cooling is left standstill a small amount of again crude product of after-filtration, yield 42.2%, HPLC 〉=92%.This crude product can be used for demethylating reaction, needn't be further purified.

Claims (4)

1. method for preparing luteolin, this method is in the presence of aluminum chloride/pyridine, and temperature of reaction is 160 ℃-180 ℃, and with 3 ', 4 '-dimethoxy-5,7-dihydroxyflavone demethylation prepares luteolin:
Intermediate 3 ', 4 '-dimethoxy-5 wherein, the 7-dihydroxyflavone by Phloroglucinol with
3,4-dimethoxy benzoyl acetic acid ethyl ester is in the presence of high boiling solvent, and the dealcoholysis dehydration prepares under the vacuum:
2. according to the process of claim 1 wherein that solvent is phenyl ether or oil of mirbane.
3. according to the process of claim 1 wherein that vacuum tightness is 1330Pa-6600Pa.
4. according to the process of claim 1 wherein that temperature of reaction is 140 ℃-160 ℃.
CNB2004100047907A 2004-03-11 2004-03-11 Process for synthesizing luteolin Expired - Fee Related CN1297552C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100047907A CN1297552C (en) 2004-03-11 2004-03-11 Process for synthesizing luteolin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100047907A CN1297552C (en) 2004-03-11 2004-03-11 Process for synthesizing luteolin

Publications (2)

Publication Number Publication Date
CN1666987A CN1666987A (en) 2005-09-14
CN1297552C true CN1297552C (en) 2007-01-31

Family

ID=35038295

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100047907A Expired - Fee Related CN1297552C (en) 2004-03-11 2004-03-11 Process for synthesizing luteolin

Country Status (1)

Country Link
CN (1) CN1297552C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013111148A1 (en) * 2011-12-13 2013-08-01 Laurus Labs Private Limited Process for preparation of luteolin

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947733B2 (en) 2007-07-31 2011-05-24 Limerick Biopharma Phosphorylated pyrone analogs and methods
CN102010393A (en) * 2010-11-09 2011-04-13 杭州福斯特药业有限公司 Method for synthesizing 5,7-dihydroxyflavone
CN103833714B (en) * 2014-02-23 2016-07-13 闻永举 Luteolin, luteoloside, the semisynthetic method of luteolin rutinoside
CN109020940A (en) * 2018-10-24 2018-12-18 陕西嘉禾生物科技股份有限公司 A kind of synthetic method of scutellarin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325393A (en) * 1998-10-30 2001-12-05 默克专利股份有限公司 Method for producing luteolin and luteolin derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325393A (en) * 1998-10-30 2001-12-05 默克专利股份有限公司 Method for producing luteolin and luteolin derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013111148A1 (en) * 2011-12-13 2013-08-01 Laurus Labs Private Limited Process for preparation of luteolin

Also Published As

Publication number Publication date
CN1666987A (en) 2005-09-14

Similar Documents

Publication Publication Date Title
CN106167449B (en) A kind of synthetic method of parahydroxyacet-ophenone
CN102653533B (en) Total synthesis method of mangostin
CN101497567B (en) Preparation of caffeic acid 3,4-dihydroxyphenyl ethyl ester and its derivative phenyl acrylic acid phenyl alkyl ester compound
CN101205223A (en) Total synthesis method of natural product barrenwort glycosides compounds
CN1297552C (en) Process for synthesizing luteolin
CN101519393A (en) Novel method for preparing Scopoletin
CN101684112A (en) Preparation method of 5,6,7,4'-tetramethoxy flavones of scutellarin and aglucone key intermediate thereof
CN102060826A (en) Method for synthesizing 7-methoxyl-4'-substituted flavonoids compound
CN102276426A (en) Novel synthetic method of 3, 4, 5-trihydroxystilbene
CN110128246B (en) Preparation method of hydroxytyrosol
CN111116339B (en) Method for artificially synthesizing curcumin and derivatives thereof
CN112939738B (en) Preparation method of 3, 5-dihydroxypentylbenzene
CN104529726B (en) A kind of preparation method of o-hydroxyacetophenone
CN102557902A (en) Preparation method for 5-fluorosalicylaldehyde
CN101033172A (en) Method for modifying synthetic veratric alcohol
CN103864747B (en) The total synthesis method of mangostin
CN113214299A (en) Gamma-biphenyldicarboxylate intermediate, synthetic method thereof and gamma-biphenyldicarboxylate synthetic method
CN105622350A (en) Synthesis method of resveratrol
CN101792451A (en) Full synthesis method of 4'',5''-dihydroxyl-5-methoxyl-[6'',6''-dimethyl pyran (2'',3'':7,8)] Hirtellanine A
CN1300134C (en) Baicalin preparing process
CN108070014A (en) A kind of preparation method of compound and its application in shellfish cholic acid difficult to understand is prepared
CN109942382B (en) Method for synthesizing vanillyl alcohol ether
Donnelly et al. α-Halogenoketones—XIV: Studies in the chemistry of 2'-hydroxyacrylophenones
Kuo et al. An efficient synthesis of a potent anti-inflammatory agent, viscolin, and its inducible nitric oxide synthase inhibitory activity
CN114315527A (en) Preparation method of resorcinol

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice

Addressee: Chen Xin

Document name: Notification of Termination of Patent Right

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070131

Termination date: 20100311